2m 2m 2m 2m 2m 2m 2m
SCYNEXIS (SCYX)
NASDAQ
$3.42$0.00 (0.00%)
Price as of Nov 12, 2026 8:58 AM EST- $34.0MMarket Cap
- -27.73%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
SCYNEXIS (SCYX)
$3.42$0.00 (0.00%)
SCYX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.42 | ||
Change | -$0.10 (-2.98%) | ||
Open | $3.62 | ||
High | $3.67 | ||
Low | $3.37 | ||
Previous Close | $3.52 | ||
Volume | 62,201 | ||
30-Day Average Volume | 69,260 | ||
1-Week Change | -11.07% | ||
1-Month Change | -16.30% | ||
1-Year Change | -27.73% | ||
3-Year Change | -74.96% | ||
5-Year Change | -91.90% | ||
Fundamentals | |||
Shares Outstanding | 10.0M | ||
Total Assets | $68.0M | ||
Market Cap | $34.0M | ||
Enterprise Value | $25.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$8.5M | ||
Free Cash Flow | -$7.5M | ||
EBIT | -$8.5M | ||
EBITDA | -$8.5M | ||
Net Working Capital | $43.7M | ||
EPS | -$0.71 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue